These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3691613)

  • 21. Disposition of ibuprofen in patients with liver cirrhosis. Stereochemical considerations.
    Li G; Treiber G; Maier K; Walker S; Klotz U
    Clin Pharmacokinet; 1993 Aug; 25(2):154-63. PubMed ID: 8403739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A; Paál M; Kádas I; Kerekes E; Jávor T
    Acta Med Hung; 1983; 40(1):17-24. PubMed ID: 6664741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of alcohol abuse and glutathione administration on the circulating levels of glutathione and on antipyrine metabolism in patients with alcoholic liver cirrhosis.
    Loguercio C; Piscopo P; Guerriero C; De Girolamo V; Disalvo D; Del Vecchio Blanco C
    Scand J Clin Lab Invest; 1996 Aug; 56(5):441-7. PubMed ID: 8869667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of (+)cyanidanol-3 on cellular immune reactions and on superoxide dismutase activity in vitro.
    Láng I; Nékám K; Deák G; Müzes G; Gonzalez CR; Kádár J; Perl A; Gergely P; Fehér J
    Free Radic Res Commun; 1987; 4(1):51-60. PubMed ID: 2976388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlordiazepoxide and oxazepam disposition in cirrhosis.
    Sellers EM; Greenblatt DJ; Giles HG; Naranjo CA; Kaplan H; MacLeod SM
    Clin Pharmacol Ther; 1979 Aug; 26(2):240-6. PubMed ID: 455893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naproxen disposition in patients with alcoholic cirrhosis.
    Williams RL; Upton RA; Cello JP; Jones RM; Blitstein M; Kelly J; Nierenburg D
    Eur J Clin Pharmacol; 1984; 27(3):291-6. PubMed ID: 6510456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyanidanol: will a hepatotrophic drug from Europe go west?
    Hepatology; 1983; 3(1):121-3. PubMed ID: 6822375
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative ultrastructural analysis of hepatoprotective effects of (+)-cyanidanol-3 on alcoholic liver damage.
    Varga M; Buris L
    Exp Mol Pathol; 1990 Apr; 52(2):249-57. PubMed ID: 2332041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trace elements (zinc, copper, manganese) in alcoholic cirrhosis: effect of chronic alcoholism].
    Zarski JP; Arnaud J; Dumolard L; Favier A; Rachail M
    Gastroenterol Clin Biol; 1985 Oct; 9(10):664-9. PubMed ID: 4065488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy.
    Cello JP; Oie S
    Eur J Clin Pharmacol; 1983; 25(2):223-9. PubMed ID: 6628505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: biochemical and histological studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):46-57. PubMed ID: 1706539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo demonstration of the cytoprotective effect of (+)-cyanidanol-3.
    Altorjay I; Dalmi L; Sári B
    Acta Physiol Hung; 1984; 64(3-4):471-4. PubMed ID: 6532130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein turnover in abstinent and non-abstinent patients with alcoholic cirrhosis.
    Hirsch S; de la Maza MP; Petermann M; Iturriaga H; Ugarte G; Bunout D
    J Am Coll Nutr; 1995 Feb; 14(1):99-104. PubMed ID: 7706618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ; Borg R
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract]   [Full Text] [Related]  

  • 35. A comprehensive evaluation of the [2-
    Borges G; van der Hooft JJJ; Crozier A
    Free Radic Biol Med; 2016 Oct; 99():128-138. PubMed ID: 27495388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism.
    Campillo B; Sherman E; Richardet JP; Bories PN
    Eur J Clin Nutr; 2001 Nov; 55(11):980-8. PubMed ID: 11641747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal methylation capacity in human liver cirrhosis.
    Geubel AP; Mairlot MC; Buchet JP; Dive C; Lauwerys R
    Int J Clin Pharmacol Res; 1988; 8(2):117-22. PubMed ID: 3378853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of (+)cyanidanol-3 in acute liver injury induced by galactosamine or carbon tetrachloride in the rat.
    Perrissoud D; Weibel I
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):285-91. PubMed ID: 7402370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism.
    Silberberg M; Morand C; Manach C; Scalbert A; Remesy C
    Life Sci; 2005 Nov; 77(25):3156-67. PubMed ID: 15979103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic absorption and metabolism of dietary procyanidin B4 in pigs.
    Bittner K; Kemme T; Peters K; Kersten S; Dänicke S; Humpf HU
    Mol Nutr Food Res; 2014 Dec; 58(12):2261-73. PubMed ID: 25263999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.